Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Taichi Hamanaka, Keiko Nishizawa, Yuji Sakasegawa, Hiroshi Kurahashi, Ayumi Oguma, Kenta Teruya, Katsumi Doh-ura
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Prions
10.1073/pnas.95.23.13363 · 1998
A systematic review of prion therapeutics in experimental models
10.1093/brain/awl150 · 2006
Prion disease: chemotherapeutic strategies
10.2174/187152612800100161 · 2012
Amyloid-binding compounds and their anti-prion potency
10.2174/15680266113136660178 · 2013
Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies
10.1099/vir.0.19754-0 · 2004
Styrylbenzoazole derivatives for imaging of prion plaques and treatment of transmissible spongiform encephalopathies
10.1111/j.1471-4159.2006.04035.x · 2006
Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner
10.1128/jvi.01563-07 · 2007
Drug resistance confounding prion therapeutics
10.1073/pnas.1317164110 · 2013
Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study
10.1212/01.wnl.0000113764.35026.ef · 2004
Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial
10.1016/s1474-4422(09)70049-3 · 2009
Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases
10.1111/j.1440-1789.2009.01058.x · 2009
Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease
10.1212/wnl.0b013e3182a9f3b4 · 2013
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial
10.1016/s1474-4422(13)70307-7 · 2014
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
10.1073/pnas.161274798 · 2001
New inhibitors of scrapie-associated prion protein formation in a library of 2,000 drugs and natural products
10.1128/jvi.77.19.10288-10294.2003 · 2003
Prophylactic effect of dietary seaweed Fucoidan against enteral prion infection
10.1128/aac.00917-06 · 2007
Anti-prion activity of protein-bound polysaccharide K in prion-infected cells and animals
10.1016/j.bbrc.2011.01.030 · 2011
Function of antimicrobial proteins in insects
1994
Insects antiviral and anticancer peptides: new leads for the future?
10.2174/092986608784966912 · 2008
Insect natural products and processes: new treatments for human disease
10.1016/j.ibmb.2011.05.007 · 2011
Insect inducible antimicrobial peptides and their applications
10.2174/1389203711209070620 · 2013
Purification, characterization, and cDNA cloning of an antifungal protein from the hemolymph of Sarcophaga peregrina (flesh fly) larvae
10.1016/s0021-9258(19)50307-6 · 1993
Isolation and characterization of a new member of the insect defensin family from a beetle, Allomyrina dichotoma
10.1006/bbrc.1996.0438 · 1996
Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation
10.1128/jvi.74.10.4894-4897.2000 · 2000
Efficacy and mechanism of a glycoside compound inhibiting abnormal prion protein formation in prion-infected cells: implications of interferon and phosphodiesterase 4D-interacting protein
10.1128/jvi.03775-13 · 2014
N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction
10.1021/bi9530550 · 1996
Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform
10.1083/jcb.129.1.121 · 1995
Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments
10.1111/j.1471-4159.2006.03889.x · 2006
Inhibition of cholesterol recycling impairs cellular PrP(Sc) propagation
10.1007/s00018-009-0158-4 · 2009
Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation
10.1074/jbc.m110.108548 · 2010
Live imaging of prions reveals nascent PrPSc in cell-surface, raft-associated amyloid strings and webs
10.1083/jcb.201308028 · 2014
Autophagy, prion infection and their mutual interactions
2010
Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro
10.1006/jmbi.2000.3840 · 2000
Complex polyamines: unique prion disaggregating compounds
10.2174/187152709789541952 · 2009
Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells
10.1128/jvi.67.2.643-650.1993 · 1993
Properties of phenoloxidase purified from larvae of the housefly
1989
Amyloidophilic compounds for prion diseases
10.2174/1871526510909010015 · 2009
Nonenzymatic glycation at the N terminus of pathogenic prion protein in transmissible spongiform encephalopathies
10.1074/jbc.m400854200 · 2004
Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques
10.1016/s0304-3940(02)00310-5 · 2002
Influence of the maillard reaction to prion protein aggregation
10.1089/rej.2009.0954 · 2010
No additional external references are available.